Lumexa Imaging Holdings, Inc.

Stage 4 · Declining · week 4

As of Oct 22, 2026, Lumexa Imaging Holdings is in Stage 4, the downtrend phase, now in week 4 (since Sep 29, 2026). It closed at $10.89, below its 200-day average.

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. More about the company

$10.89

+0.74% today

$1.0B · Small cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is LMRI early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2025-12-11 → 2026-10-22

S? 42w

2025-12-112026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S4 3w current

Total tracked: 45 weeks across 2 stage runs.

LMRI among Medical Devices139th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…139	LMRILumexa Imaging Holdings, Inc.	Stage 4 · wk 4	—	+7.4%

vs 52W High

—

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 4

1w13w26w

Week 4, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-3.2%

200 DMA: $11.25

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.74x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+7.4%

-0.4%

+15.7%

YTD

-37.9%

—

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S4

Wk 4 · Vol 0.74x

2026-10-21S4

Wk 4 · Vol 0.68x

2026-10-20S4

Wk 4 · Vol 0.44x

2026-10-19S4

Wk 3 · Vol 0.64x

2026-10-16S4

Wk 3 · Vol 0.74x

2026-10-15S4

Wk 3 · Vol 0.86x

2026-10-14S4

Wk 3 · Vol 0.46x

2026-10-13S4

Wk 3 · Vol 0.67x

2026-10-12S4

Wk 2 · Vol 0.42x

2026-10-09S4

Wk 2 · Vol 0.83x

2026-10-08S4

Wk 2 · Vol 1.11x

2026-10-07S4

Wk 2 · Vol 0.37x

Moving averages & range

50 DMA

$11.14

200 DMA

$11.25

52W High

—

52W Low

—

5D Low

$10.68

Resistance levels (recent highs)

20d High

$10.89

60d High

$12.42

120d High

$12.70

250d High

—

Next resistance

+14.0%

to 60d High

Dividend Yield

0.00%

P/B 1.7

Lumexa Imaging Holdings: quick answers

What stage is Lumexa Imaging Holdings in?

As of Oct 22, 2026, Lumexa Imaging Holdings (LMRI) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 29, 2026 and is in week 4. What the four stages mean

Is Lumexa Imaging Holdings in an uptrend?

No. Lumexa Imaging Holdings is in a Stage 4 downtrend. It trades 3.2% below its 200-day average.

How has Lumexa Imaging Holdings performed over the past year?

As of Oct 22, 2026, Lumexa Imaging Holdings is down 37.9% so far in 2026.

Which sector and industry is Lumexa Imaging Holdings in?

Lumexa Imaging Holdings is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.